In this study, the classification of patients by clinical manifestations and the addition of β2GPI to the HUVECs allowed us to understand the differences that aPL present in endothelial activation and dysfunction, representing an adequate methodology in the study of APS. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.